2023 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2023)-3¿ù 31ÀÏ(2ÀÏÂ÷) : 2023-03-31
±³À°ÀÏÀÚ : 2023-03-31
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ
±³À°ÁÖÁ¦ : 2023 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2023)-3¿ù 31ÀÏ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í ÀüÀÓÀÇ/¿¬±¸¿ø/°£È£»ç/ÀüÀÓÀÇ 100000¿ø, ºñȸ¿ø 300000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 09:00~09:25 Engineering next-generation T cells for cancer immunotherapy Yvonne Chen(University of California, USA)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 09:25~09:50 Development of CAR-T therapy for acute lymphoblastic leukemia Hyoung Jin Kang(Seoul National University College of Medicine, Korea)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 09:50~10:15 Updates on the latest developments in CAR-T therapies Hiroshi Fujiwara(Mie University, Jspan)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 10:30~11:15 The role of the intestinal microbiome in cancer immunotherapy Marcel van den Brink(Memorial Sloan Kettering Cancer Center, USA)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 11:15~12:00 Clinical Significance of bZIP in-frame CEBPA-mutated normal karyotype acute myeloid leukemia Seo-Yeon Ahn(Chonnam National University Hwasun Hospital, Korea)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 12:15~13:05 Recent advances in the pathogenesis and treatment of aplastic anemia Kohei Hosokawa(Kanazawa University, Japan)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 13:20~14:50 A Phase 1 study of the safety, tolerability, pharmacokinetics and pharmacodynamics of MG1113 in healthy subjects and hemophilia patients Jung Woo Han(Yonsei University, Korea)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 15:05~15:30 Overview of AA diagnosis and treatment in NIHBT, VietNam Nguyen Thi Thao(National Institute of Hematology and Blood Transfusion, Vietnam)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 15:30~15:55 Determining the barriers to successful CAR T cell therapy for AML Miriam Y Kim(University of Washington, USA)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 15:55~16:20 Adoptive T cell transfer of three universal tumor associated antigens-specific T cells for the treatment of AML Byung Sik Cho(The Catholic University of Korea)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 16:35~17:00 Cell-free DNA profiling for monitoring of complications of hematopoietic cell transplantation Iwijn De Vlaminck(Cornell University, USA)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 17:00~17:25 Microbial cell-free DNA sequencing to predict bloodstream infection in pediatric cancer patients Charles Gawad(St. Jude Children)
±³À°½Ã°£ 03-31 ºñ½ºÅ¸È¦ 17:25~17:50 Clinical applications of circulating tumor DNA analysis in lymphoma Seung-Tae Lee(Yonsei University College of Medicine, Korea)